Finer Wealth Management Inc. Has $398,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Finer Wealth Management Inc. decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 763 shares of the medical equipment provider’s stock after selling 74 shares during the period. Finer Wealth Management Inc.’s holdings in Intuitive Surgical were worth $398,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of ISRG. Atala Financial Inc acquired a new stake in Intuitive Surgical during the fourth quarter worth $25,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the fourth quarter valued at about $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical in the fourth quarter worth about $28,000. Finally, Summit Securities Group LLC acquired a new position in Intuitive Surgical in the fourth quarter worth about $30,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.4 %

Shares of ISRG stock opened at $488.27 on Wednesday. The firm has a market cap of $173.91 billion, a price-to-earnings ratio of 76.17, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a 50-day moving average price of $528.70 and a 200 day moving average price of $532.45.

Insider Activity

In other news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ISRG. Citigroup increased their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Leerink Partners lifted their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Bernstein Bank boosted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Finally, Erste Group Bank lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.